593 related articles for article (PubMed ID: 33739919)
1. Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.
Robinson DE; Ali MS; Strauss VY; Elhussein L; Abrahamsen B; Arden NK; Ben-Shlomo Y; Caskey F; Cooper C; Dedman D; Delmestri A; Judge A; Javaid MK; Prieto-Alhambra D
Health Technol Assess; 2021 Mar; 25(17):1-106. PubMed ID: 33739919
[TBL] [Abstract][Full Text] [Related]
2. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Safety of Oral Bisphosphonates in Moderate-to-Severe Chronic Kidney Disease: A Binational Cohort Analysis.
Robinson DE; Ali MS; Pallares N; Tebé C; Elhussein L; Abrahamsen B; Arden NK; Ben-Shlomo Y; Caskey FJ; Cooper C; Dedman D; Delmestri A; Judge A; Pérez-Sáez MJ; Pascual J; Nogues X; Diez-Perez A; Strauss VY; Javaid MK; Prieto-Alhambra D
J Bone Miner Res; 2021 May; 36(5):820-832. PubMed ID: 33373491
[TBL] [Abstract][Full Text] [Related]
5. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.
Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610
[TBL] [Abstract][Full Text] [Related]
6. Unicompartmental compared with total knee replacement for patients with multimorbidities: a cohort study using propensity score stratification and inverse probability weighting.
Prats-Uribe A; Kolovos S; Berencsi K; Carr A; Judge A; Silman A; Arden N; Petersen I; Douglas IJ; Wilkinson JM; Murray D; Valderas JM; Beard DJ; Lamb SE; Ali MS; Pinedo-Villanueva R; Strauss VY; Prieto-Alhambra D
Health Technol Assess; 2021 Nov; 25(66):1-126. PubMed ID: 34812138
[TBL] [Abstract][Full Text] [Related]
7. Non-benzodiazepine hypnotic use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort studies.
Richardson K; Savva GM; Boyd PJ; Aldus C; Maidment I; Pakpahan E; Loke YK; Arthur A; Steel N; Ballard C; Howard R; Fox C
Health Technol Assess; 2021 Jan; 25(1):1-202. PubMed ID: 33410736
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.
Davis S; Martyn-St James M; Sanderson J; Stevens J; Goka E; Rawdin A; Sadler S; Wong R; Campbell F; Stevenson M; Strong M; Selby P; Gittoes N
Health Technol Assess; 2016 Oct; 20(78):1-406. PubMed ID: 27801641
[TBL] [Abstract][Full Text] [Related]
9. Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCT.
Witham MD; Band M; Chong H; Donnan PT; Hampson G; Hu MK; Littleford R; Lamb E; Kalra PA; Kennedy G; McNamee P; Plews D; Rauchhaus P; Soiza RL; Sumukadas D; Warwick G; Avenell A
Health Technol Assess; 2020 Jun; 24(27):1-90. PubMed ID: 32568065
[TBL] [Abstract][Full Text] [Related]
10. Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark.
Ali MS; Ernst M; Robinson DE; Caskey F; Arden NK; Ben-Shlomo Y; Nybo M; Rubin KH; Judge A; Cooper C; Javaid MK; Hermann AP; Prieto-Alhambra D
Arch Osteoporos; 2020 Jun; 15(1):81. PubMed ID: 32483674
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study.
Sahota O; Narayanasamy M; Bastounis A; Paskins Z; Bishop S; Langley T; Gittoes N; Davis S; Baily A; Holmes M; Leonardi-Bee J
Health Technol Assess; 2024 Apr; 28(21):1-169. PubMed ID: 38634483
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates for steroid-induced osteoporosis.
Allen CS; Yeung JH; Vandermeer B; Homik J
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD001347. PubMed ID: 27706804
[TBL] [Abstract][Full Text] [Related]
13. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
14. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.
Gould DW; Doidge J; Sadique MZ; Borthwick M; Hatch R; Caskey FJ; Forni L; Lawrence RF; MacEwen C; Ostermann M; Mouncey PR; Harrison DA; Rowan KM; Young JD; Watkinson PJ
Health Technol Assess; 2022 Feb; 26(13):1-58. PubMed ID: 35212260
[TBL] [Abstract][Full Text] [Related]
15. The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.
Guthrie B; Rogers G; Livingstone S; Morales DR; Donnan P; Davis S; Youn JH; Hainsworth R; Thompson A; Payne K
Health Soc Care Deliv Res; 2024 Feb; 12(4):1-275. PubMed ID: 38420962
[TBL] [Abstract][Full Text] [Related]
16. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate therapy for osteogenesis imperfecta.
Dwan K; Phillipi CA; Steiner RD; Basel D
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005088. PubMed ID: 27760454
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
